Developing Immune Profiling Solutions and T-Cell Diagnostics
Developing a Novel Portfolio of FluoroSpot T-Cell Diagnostics for Indications Associated with Chronic Inflammation and T-Cell Exhaustion
Research Tools to Investigate T-Cell Immunity
ViraxImmune™ Products
Peptide Pools
Pathogen-specific linear peptides containing immunodominant epitopes, designed for efficient T-Cell stimulation.
ELISpot/FluoroSpot Kits
Pre-coated plates and reagents to analyse the immune response at cellular level. Multiple cytokines available.
Antibodies
High-affinity antibodies for the detection of cytokines and other biomarker in ELISA, Flow cytometry and ELISpot assays.
T-Cell Testing
ELISpot assays are one of the most sensitive and specific techniques available for monitoring T-Cell responses permitting the ex vivo identification of cells actively secreting signaling proteins or antibodies. In addition the assay is relatively fast, highly efficient and the limit of detection achieved 1 in 100,000 cells.
Diagnosis of Viral Diseases
Immune Profiling is the detailed study and characterization of both the innate and adaptive immune responses to provide crucial insights into disease mechanisms and aiding in the development of novel therapeutic strategies. Our ViraxImmune™ IVD platform is not restricted to a single disease or condition.
Find out more about our company activites
Latest News and Media
![](https://viraxbiolabs.com/wp-content/uploads/2024/07/Jeff-Hurwitz-Gordon-Powell_Instagram_Instagram-1024x1024.jpg)
Jeff Hurwitz and Gordon Powell Join the Virax Biolabs Team
This week, we’re pleased to be welcoming Jeff Hurwitz and Gordon Powell to the team. Their decades of experience in the in-vitro diagnostics (IVD) space will be a great addition
![](https://viraxbiolabs.com/wp-content/uploads/2024/06/From-Lab-to-Launch-02-1024x1024.jpg)
![](https://viraxbiolabs.com/wp-content/uploads/2024/06/ImmunologySummit-2024-1024x576.jpg)
![](https://viraxbiolabs.com/wp-content/uploads/2024/05/Long-COVID-Podcast-copy-02-1024x1024.jpg)
![](https://viraxbiolabs.com/wp-content/uploads/2024/04/Long-COVID-Podcast-02-1024x1024.jpg)
![](https://viraxbiolabs.com/wp-content/uploads/2024/04/Virax-ImmuneSelect-Launch-25.04.24_Instagram-1024x1024.jpg)
Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
Sign up for more information about our products and company updates